{
    "nct_id": "NCT06633926",
    "official_title": "Integrative Approaches for Cancer Survivorship: A Multi-Site Feasibility and Acceptability Study (Aim 2)",
    "inclusion_criteria": "1. Age >= 18\n2. Able to understand study procedures and to comply with them for the entire length of the study.\n3. Able to read, write, and understand English.\n4. Ability of individual or legal guardian/representative to understand a verbal informed consent document, and the willingness to sign it.\n5. Non-metastatic breast cancer patients who are between 1 and 36 months after completion of primary treatment (i.e., surgery, radiotherapy, chemotherapy) and are in a complete remission.\n6. Participants should have received chemotherapy as part of their primary treatment.\n7. Have an impaired quality of life (report a score of 5 or less on question 30 of the European Organisation for Research and Treatment of Cancer Quality of Life Cancer questionnaire (EORTC-QLQ-C30). \"How would you rate your overall quality of life during the past week?\"\n8. Karnofsky Performance Status Score (KPS) >=60\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Contraindication to any study-related procedure or assessment.\n2. Metastatic disease and receiving chemotherapy or radiotherapy at the time of study enrollment (participants with non-metastatic disease who are receiving anti-Her2 directed treatment alone in the adjuvant setting are eligible).\n3. Participants are within 1 month after surgery for cancer, including breast reconstructive surgery but not including implant exchange.\n4. Cancer surgery planned during the initial 6-month study period.\n5. Been on adjuvant hormone therapy (for breast cancer) less than 2 months at the time of enrollment.\n6. Received Ayurvedic treatment during the 3 months preceding enrollment.\n7. Severe depression assessed by the Patient Health Questionnaire Depression scale (PHQ-8) using a cutoff score of 20 or higher or severe anxiety assessed by the Generalized Anxiety Disorder Questionnaire (GAD-7) using a cutoff score of 15 or higher.",
    "miscellaneous_criteria": ""
}